Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Entheon Biomedical Corp (ENTBF)

Entheon Biomedical Corp (ENTBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cybin (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate CYB004 Clinical Program Investor Brand Network - Thu Aug 4, 2022

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition...

CYBN.NE : 13.8000 (+3.60%)
CYBN : 9.61 (+3.11%)
ENBI.CN : 0.1700 (unch)
ENTBF : 0.0959 (-11.86%)
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders FinancialNewsMedia - Wed Jul 27, 2022

Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam...

CYBN.NE : 13.8000 (+3.60%)
SILO : 0.8780 (+5.16%)
FTRP : 4.2105 (+1.07%)
FTRP.TO : 1.09 (+5.83%)
ATAI : 1.1900 (unch)
CYBN : 9.61 (+3.11%)
ENBI.CN : 0.1700 (unch)
ENTBF : 0.0959 (-11.86%)
CMPS : 3.97 (+1.28%)
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders PR Newswire - Wed Jul 27, 2022

/PRNewswire/ -- For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many...

ENTBF : 0.0959 (-11.86%)
FTRP.TO : 1.09 (+5.83%)
SILO : 0.8780 (+5.16%)
FTRP : 4.2105 (+1.07%)
ATAI : 1.1900 (unch)
CYBN : 9.61 (+3.11%)
CMPS : 3.97 (+1.28%)
Cybin (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Investor Brand Network - Mon Jul 11, 2022

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that, through its wholly-owned subsidiary Cybin IRL Limited,...

CYBN.NE : 13.8000 (+3.60%)
CYBN : 9.61 (+3.11%)
ENBI.CN : 0.1700 (unch)
ENTBF : 0.0959 (-11.86%)
Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical Business Wire - Mon Jul 11, 2022

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) (“ Cybin ” or the “ Company ”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced that, through...

CYBN.NE : 13.8000 (+3.60%)
CYBN : 9.61 (+3.11%)
ENBI.CN : 0.1700 (unch)
ENTBF : 0.0959 (-11.86%)
Cybin Acquires DMT Clinical Study from Entheon Biomedical Business Wire - Tue Jun 7, 2022

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) ( Cybin or the Company ), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced that, through its wholly-owned...

CYBN.NE : 13.8000 (+3.60%)
CYBN : 9.61 (+3.11%)
ENBI.CN : 0.1700 (unch)
ENTBF : 0.0959 (-11.86%)
Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research Globe Newswire - Wed Jun 1, 2022

AI-driven discovery platform enables new way to find novel pathways, as well as progress towards identifying patients who may better respond to drugs in...

OTC.VN : 0.330 (+3.13%)
EHVVF : 0.0007 (unch)
ENBI.CN : 0.1700 (unch)
ENTBF : 0.0959 (-11.86%)
Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) Featured in Virtual Coverage of Benzinga’s Small Cap Conference Investor Brand Network - Tue Dec 7, 2021

Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) is researching and developing psychedelic drugs for the treatment of addiction disorders. With a focus on the psychedelic DMT molecule, Entheon’s upcoming...

ENBI.CN : 0.1700 (unch)
ENTBF : 0.0959 (-11.86%)
Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics Globe NewsWire - Mon Aug 30, 2021

NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- Microdose Psychedelic Insights , a cutting-edge media company focused on promoting content, financial analysis, and engaging events...

ENBI.CN : 0.1700 (unch)
ENTBF : 0.0959 (-11.86%)
DMT.VN : 0.150 (-6.25%)
AGN.CN : 0.0650 (unch)
AGNPF : 0.0414 (+0.98%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot